Gaviscon Use 2 Days Post-Gastric Bypass
Proton pump inhibitors (PPIs), not Gaviscon, are the recommended acid suppression therapy after gastric bypass surgery, and should be started immediately postoperatively for at least 30 days. 111
Guideline-Based Recommendations
The 2022 ERAS Society guidelines provide a strong recommendation (moderate evidence) that PPI prophylaxis should be considered for at least 30 days after Roux-en-Y gastric bypass surgery 111. The 2019 AACE/ACE guidelines further specify that prophylactic PPI therapy should be considered for 90 days to 1 year after bariatric procedures, depending on risk (Grade B recommendation) 22.
Why PPIs Over Gaviscon?
Mechanism and Timing Considerations
Gaviscon works by forming an alginate raft that floats on gastric contents and displaces the "acid pocket" away from the gastroesophageal junction 345. This mechanism requires:
- An intact gastric anatomy with normal gastric contents
- Food in the stomach to create the raft formation
- The ability to take adequate oral volumes
At 2 days post-op, patients are typically:
Clinical Rationale for PPI Priority
The primary concern post-gastric bypass is preventing anastomotic ulcers and leaks, which occur at the gastrojejunal anastomosis. PPIs provide:
- Sustained acid suppression (not just mechanical barrier)
- Protection during the critical healing period
- Reduced risk of marginal ulcers (a known complication) 22
Practical Answer for Day 2 Post-Op
If the patient is not already on a PPI, start one immediately. If they are experiencing reflux symptoms despite PPI therapy at day 2 post-op:
First, optimize PPI dosing (may need twice daily dosing)
Evaluate for complications - early reflux symptoms could indicate:
- Anastomotic stricture
- Pouch dilation
- Technical issues requiring surgical evaluation
Gaviscon could theoretically be added as adjunctive therapy, but:
- There is no evidence supporting its use in the immediate post-bariatric surgery period
- The altered anatomy may limit its effectiveness
- Volume tolerance at day 2 is typically poor
- It should never replace PPI therapy
Important Caveats
- NSAIDs should be avoided as they increase risk of anastomotic ulceration 22, though recent data suggests this may be less concerning after sleeve gastrectomy 6
- If reflux symptoms persist despite PPI, consider H2 receptor blockers or sucralfate as alternatives 22
- Persistent symptoms warrant endoscopic evaluation to rule out mechanical complications 22
Bottom Line
While Gaviscon is not contraindicated per se, it is not the appropriate first-line therapy at 2 days post-gastric bypass. The patient should be on a PPI. If they need additional symptom control beyond PPI therapy this early, investigate for complications rather than simply adding symptomatic treatment.